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Abstract
Background: There is a need for assistance from primary care mental health workers in general
practice in the Netherlands. General practitioners (GPs) experience an overload of frequent
attenders suffering from psychological problems. Problem Solving Treatment (PST) is a brief
psychological treatment tailored for use in a primary care setting. PST is provided by nurses, and
earlier research has shown that it is a treatment at least as effective as usual care. However,
research outcomes are not totally satisfying. This protocol describes a randomized clinical trial on
the effectiveness of PST provided by nurses for patients in general practice. The results of this
study, which currently being carried out, will be presented as soon as they are available.
Methods/design: This study protocol describes the design of a randomized controlled trial to
investigate the effectiveness and cost-effectiveness of PST and usual care compared to usual care
only.
Patients, 18 years and older, who present psychological problems and are frequent attenders in
general practice are recruited by the research assistant. The participants receive questionnaires at
baseline, after the intervention, and again after 3 months and 9 months. Primary outcome is the
reduction of symptoms, and other outcomes measured are improvement in problem solving skills,
psychological and physical well being, daily functioning, social support, coping styles, problem
evaluation and health care utilization.
Discussion: Our results may either confirm that PST in primary care is an effective way of dealing
with emotional disorders and a promising addition to the primary care in the UK and USA, or may
question this assumption. This trial will allow an evaluation of the effects of PST in practical
circumstances and in a rather heterogeneous group of primary care patients. This study delivers
scientific support for this use and therefore indications for optimal treatment and referral.
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Background
In primary care the prevalence of psychological problems
(e.g. depression, anxiety, stress, somatization, unex-
plained or functional symptoms) ranges from 30% to
70%. Patients with these complaints, symptoms or disor-
ders frequently visit their general practitioner [1] and only
3% of all patients are referred to a specialist. This implies
that mental health care is a core activity in primary care
[2]. For many of these complaints and symptoms no evi-
dence-based treatment is available [3]. There is a clear
need for an effective treatment for common mental disor-
ders in primary care.
Problem Solving Treatment(PST) in primary care
In 1971 D'Zurilla and Goldfried published a theory in
which problem-solving was defined as a cyclic process in
five stages: problem orientation; problem definition; gen-
eration of alternative solutions; decision making, and
solution implementation and was called problem solving
therapy [4]. Since then, problem solving therapy has been
applied for a wide range of psychological problems in all
kinds of areas. In 1995 Gath and Mynors-Wallis con-
ducted an experiment based on a basic form of PST in pri-
mary care. This is strictly protocollized and based on the
principles of cognitive behavioral therapy (CBT) [5]. The
treatment is brief and focuses on practical skill-building.
It consists of a maximum of six sessions, each of which
contains seven steps of problem-solving (see Figure 1)
which are applied in a systematic manner towards prob-
lem resolution. The rationale is that it increases the
patient's understanding of the relationship between every-
day problems and psychological symptoms. The goal of
PST is to help patients to regain control of their lives.
There is evidence that PST can be an effective way of help-
ing patients, and in particular patients with depression, to
deal with psychological problems. One earlier study
showed the superiority of PST over placebo but no superi-
ority over amitryptiline [6]. A second study showed equal
results in clinical outcomes between patients who
received PST and patients who received usual care from
their GP [6]. When community nurses provided PST the
results were the same as for usual care from the GP, but
the economic evaluation was more positive for the PST
group [7]. Patients with minor depression who received
PST showed the same improvement as patients who
received a placebo, but their symptoms improved
somewhat more rapidly than those of patients who
received a placebo during the latter treatment. Patients
with dysthymia who received PST and paroxetine showed
significantly more improvement than patients who
received a placebo [8]. Compared to other GP interven-
tions there is good evidence PST is effective for major
depression [1].
PST provided by nurses as a potential option
Patients with psychological problems need more time
than is available in general practice. The usual 10-minute
consultation with a GP is generally too short to explain
and explore these psychological problems. To complicate
matters more, these problems are often interwoven with
physical issues such as fatigue and sleeplessness. Further-
more, patients are ambiguous in presenting their symp-
toms [9]. Given this fact, in combination with the high
prevalence of psychological problems in primary care,
treating these patients will result in a shift of tasks to
nurses. Especially nurses who are skilled in working with
psychiatric patients, may become indispensable in pri-
mary care [10]. Nurses can be successfully trained in the
techniques of PST and can provide effective PST for pri-
mary care patients [11]. Recent results show that a CBT
protocol for panic-disorder can adhered by a therapist
with minimal of or no CBT experience [12].
There are several issues which stimulate further investiga-
tion. First, PST may be the way forward in the Nether-
lands, where GPs have a heavy workload and patients
need better tailored collaborative forms of care, focused
on self-help and education.
There are still very few nurses working in Dutch general
practice and although preliminary experiments are taking
place to enhance and define the role of nurses in primary
care, PST could be a welcome innovation in their task pro-
file. So, innovative projects in primary care in the Nether-
lands are needed.
Secondly, there is a lack of research outcomes on the effec-
tiveness of talking treatment for anxiety symptoms in
patients. In this trial, patients with depressive as well as
anxiety symptoms will be included. Only one study has
reported substantially better outcomes for primary care
patients with panic disorder, who received CBT and phar-
macotherapy from a therapist with minimal or no CBT
experience, like a nurse, than patients with usual care only
from their GP [12].
Third, PST in primary care could prevent or stimulate a
referral to secondary care for patients with complaints
which cannot be treated in primary care. This would also
stimulate better tailored collaborative forms of care and
prevent the deterioration of complaints.
The primary aim of the present trial is therefore to investi-
gate whether PST for patients with psychological prob-
lems provided by nurses in primary care, is effective.BMC Family Practice 2005, 6:42 http://www.biomedcentral.com/1471-2296/6/42
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Methods
Design
A randomized, controlled trial is being carried out to eval-
uate the effects of PST. At least 160 primary care patients
will be included; 80 will receive usual care and PST and 80
will receive usual care only. At baseline, after the interven-
tion and after 3 and 9 months the patients will be asked
to fill in a questionnaire, and at baseline and after 9
months they will be asked to cooperate in a (diagnostic)
telephonic interview. Primary outcome is the reduction of
symptoms, and other outcomes measured are improve-
ment in problem solving skills, psychological and physi-
cal well being, daily functioning, social support, coping
styles, problem evaluation and health care utilization.
The Medical Ethics Committee of the VU Medical Center
in Amsterdam approved the study design.
Study population
The study population will consist of Dutch-speaking
adults (18+) who visited a participating GP more than
three times in the last six months. To asses whether psy-
chological problems are present, the General Health
Questionnaire 12 item version (GHQ-12) will be used for
screening [13]. At random we visited the participating GP
practices to ask patients to fill in our screening question-
naire while they where waiting to see their GP. If they had
a score negative score on more then three out of twelve
questions (indicating the presence of psychological prob-
lems) and if they were willing to participate, they were
included. Patients were excluded from the study if they:
received any treatment in mental health care; suffered
from a severe (psychical) disease or personality-disorder;
accepted no other explanation for their complaints than a
somatic rationale; and patients with an non-consistent
medication for anxiety or depression. Patients with severe
drug addictions, suicidal wishes or mental retardation
were excluded. An external researcher conducted block-
randomization, so the allocation was concealed.
Intervention: usual care and PST provided by nurses
Consistent with earlier research on PST training skills
[11], the nurses in this RCT were trained for two days by
experienced supervisors who were also members of the
original Oxford research group[6]. The nurses were closely
supervised by means of video and audiotapes. A CBT
The seven stages of problem solving treatment Figure 1
The seven stages of problem solving treatment.
Problem Solving Treatment contains of seven stages:
1. Explanation and rationale 
2. Problem definition
3. Establishing achievable goals
4. Generating  solutions
5. Selecting preferred solution 
6. Implementing  solution
7. Evaluation of progress 
Characteristics:
x 4-6 sessions 
x first session ma. 60 min. next sessions max. 30 min. 
x strategy for coping with present and future problems
x role of therapist decreasing: patient taking over controlBMC Family Practice 2005, 6:42 http://www.biomedcentral.com/1471-2296/6/42
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supervisor will carry out supervision after the training, for
one hour every three weeks. The nurses will deliver audio-
tapes and PST protocol forms to the supervisor. Consist-
ent with advice in earlier research [11] before the nurses
started treating patients in the trial, they treated four
patients to practice their problem-solving skills after the
training. The patients are also seen by their GP for general
health management if necessary.
Usual care: health management provided by the GP
The consult is intended to be as natural as possible so that
the GP will not influence the quality of the usual care pro-
vided. Many GPs use the guidelines issued by the Dutch
College of General Practitioners [14]. The guidelines for
psychological complaints such as anxiety and depression
describe management options as (anti-anxiety of anti-
depressant) medication and/or 'watchful waiting' if a
referral seems unnecessary [15].
Outcome measures
Primary outcome: reduction of symptoms measured with the HADS
The Hospital Anxiety and Depression Scale (HADS, [16])
is used to monitor symptom levels of anxiety and depres-
sion in the study population. The questionnaire consists
of 14 items to which answers can be given on a 4-point
scale (0–3). The HADS is considered to be unbiased by
coexisting general medical conditions, and changes in
HADS scores can therefore be used to calculate an objec-
tive effect size of the treatment provided (calculations
described in 'Sample size'). In the Dutch validation of the
HADS [16] the primary care patients have a mean of 6.2
(SD 3.8)for anxiety and 3.7(SD 3.4) for depression with a
total mean of 9.9 (SD 6.1). Reliability for these patients is
a Cronbach's alpha of .82 for the total score. The HADS is
found to perform well in assessing the severity of symp-
toms [17].
Secondary outcomes: reduction of symptoms measured with the 
PHQ
The Patient Health Questionnaire (PHQ) is designed to
facilitate the diagnosis of common mental disorders in
primary care patients [18]. The PHQ is a self report ver-
sion of the Primary Care Evaluation of Mental Disorders
(PRIME-MD). The questions do not only focus on mood
disorders but also about functional impairments, life
stressors and specific events (such as menstruation, preg-
nancy and childbirth). Its diagnostic validity is good, and
patients feel comfortable filling in the questionnaire [19].
There is a 15-item questionnaire for men and a 16-item
questionnaire for women, and the scoring range varies.
We consider that a decrease in the score on this question-
naire after the intervention represents a reduction in
mood disorders, functional impairments, life stressors
and distress about specific events.
Improvement in problem-solving skills
The Social Problem Solving Skills-Revised (SPSI-R, 15) is
a 52-item, self-report inventory, which is designed by
D'Zurilla to measure problem-solving skills [20]. The
SPSI-R consists of five factors: 1) positive problem orien-
tation (PPO), 2) negative problem orientation(NPO), 3)
rational problem solving (RPS), 4) impulsivity/careless-
ness style (ICS) and, 5) avoidance style(AS). Alphas for
these five scales range from .76 to .92 [21] an test-retest
reliability ranges from .72 to .88 [20].
Psychological and physical well-being
This will be measured with the Short Form-36 (SF-36)
which contains 36 questions and standardized response
options and relating to eight different areas (multi-item):
physical functioning, role limitations due to psychical
health problems, bodily pain, general health perceptions,
vitality, social functioning, role limitations due tot emo-
tional problems, and general mental health [22]. The
mean alpha for reliability in the general population is
good, as well as validity which makes the SF-36 a practical
instrument for use in the general population.
Social support
The Social Support Inventory is a questionnaire which
comprises 20 descriptions of social support pertaining to
emotional support, informative support, social compan-
ionship, or instrumental support. Together these items
give an overall representation of satisfaction with social
support (the perceived adequacy). It is a reliable and brief
measurement instrument which is not influenced by psy-
chological distress [23].
Coping-styles
The Ways of Coping Questionnaire (WAYS) (the Dutch
adaption is called the VOMS: Vragenlijst over Omgaan
met Situaties) is based on the Lazarus and Folkman trans-
actional coping theory of [18]. It measures coping proc-
esses, not coping dispositions or styles. The WAYS can
assess and identify thoughts and actions that individuals
use to cope with stressful encounters in everyday life. The
WAYS measures eight coping factors: confrontive coping,
distancing, self-controlling, seeking social support,
accepting responsibility escape-avoidance, planful prob-
lem solving, and positive reappraisal.
Rumination
Actual scientific reports suggest that rumination is a signif-
icant, and probably prognostic, factor for depression. The
rumination scale (RRS) measures the extend to which
people ruminate [24]. Rumination is seen as a coping
style and characterizes depressive mood. The reliability is
good and its validity is satisfying [25,26].BMC Family Practice 2005, 6:42 http://www.biomedcentral.com/1471-2296/6/42
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Problem evaluation
This will be assessed with a brief, qualitative question-
naire about medical outcomes, the care, the illness and
the treatment of the patients, as experienced by the
patients, to complement all the quantitative question-
naires. We chose the PSYCHLOPS(also known in the
literature as MYMOP [27,28]) to evaluate the problems
patients experience and the progress they make over time.
Health care utilization
The Trimbos/iMTA questionnaire for Costs associated
with Psychiatric Illness (Tic-P) is used to measure the
amount of health care received by the patients and to reg-
ister sickness absence from work [29] Furthermore, we
chose the EQ-5D (or Euroqol, [30]) because this is a
standardized measurement instrument for a wide range of
health conditions which provides a simple descriptive
profile and a single index value for health status. The EQ-
5D (or EuroQol) was originally designed to complement
other instruments such as the SF-36, and it is adminis-
tered to assess a patient's general health status, in 5
dimensions: mobility, self-care, usual activities, pain/dis-
comfort and anxiety/depression[1]. Because each of the
five dimensions can be sub-divided into 3 levels a total of
243 health states can be assessed. Using the Dolan model
(1997) the total score will be expressed in utilities [31].
The official Dutch translation of the Euroqol will be
administered [31,32]. Incremental cost-effectiveness
ratios will be calculated, in which the difference in costs
between intervention subjects and control subjects will be
divided by the difference in effects between both groups.
Incremental cost-utility ratios will also be calculated in
which the difference in costs between the two groups will
be divided by the difference in QALYs gained between the
two groups.
Power/analysis
Randomization takes place at patient level. To evaluate
the effects of the randomization, descriptive statistics will
be used to compare the baseline measurements of the two
groups. If necessary, differences between baseline varia-
bles on relevant characteristics (such as baseline HADS
score) will be entered as covariates in the analysis.
To detect a clinically relevant difference between interven-
tions (effect size of 0.4) with the primary outcome meas-
ure HADS (power of .90 and an alpha of .05) 130
completers are needed. In both conditions there will be
65 completers. We estimate the drop-out rate to be on
20%, so we therefore need 160 participants. If 20 practices
cooperate, we will need to include 8 patients in every prac-
tice. We expect a non-response of 50%, so we will need to
screen 16 patients in every practice. In a sample of patients
with mixed symptoms of anxiety and depression, Cropper
et al. [33]observed a mean overall HADS score of 6.25 at
baseline. In the Dutch validation [16] the primary care
patients have a mean on anxiety of 6.2 (SD 3.8) and
3.7(SD 3.4) for depression with a total mean of 9.9
(SD6.1). We consider a standardized mean difference
(SMD) of 0.4 (p = 0,05) on the primary outcome (HADS)
to represent a relevant improvement in the PST group ver-
sus the usual care group[34].
Analysis
Linear regression models will be used to examine differ-
ences in investigate on the HADS. Scores will be entered
in a repeated measure design (GLM), and (optional) cov-
ariates will be differences at baseline level. Repeated meas-
ures with several independent variables will be used to
investigate differences in improvement in all secondary
outcome measures between groups. The analyses will be
performed on a per protocol basis ('completers'), as well
as according to the 'intention-to-treat' principle. Trend
analyses will also allow 'last observation carried forward'
analyses. To assess whether protocol deviations have
caused bias, the results of the intention-to-treat analyses
will be compared with analyses of the PST group, includ-
ing the completers.
Sample size
A GP in the Netherlands has an average of 80 consulta-
tions a week (children excluded). Six of the patients who
consult their GP had done so more than three times in the
previous six months and were 'frequent attenders'. With a
response of 50%, three patients a week per general prac-
tice will be sufficient, but: only one third of them will
meet the inclusion criteria. This implies that 1 patient can
be included per practice per week. To include 160 patients
with a screening in two practices per week, will take
approximately one and a half years.
Arguments for publishing a design
The primary goal of presenting the design of this study
before the results are available is to offer the reader the
opportunity to consider the methodological quality of
this study more critically and this is also a benefit for car-
egivers, because this extensive information provides more
insight into the practical applications of the study
intervention.
Publication also prevents publication-and-analysis bias.
Trials that lead to adverse or negative results are less likely
to be submitted for publication [35]. This can be avoided
by publishing a priori the design of a study and the plans
for analysis. Not only will the researchers be more
inclined to publish the results, but transparency will also
be increased and, in any case, data can be requested from
the researcher for inclusion in a systematic review.BMC Family Practice 2005, 6:42 http://www.biomedcentral.com/1471-2296/6/42
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Discussion
Our results may either confirm that PST in primary care is
an effective way of dealing with emotional disorders and
a promising addition to the primary care in the UK and
USA, or may question this assumption. This trial will
allow an evaluation of the effects of PST in practical
circumstances and in a rather heterogeneous group of pri-
mary care patients.
Strengths and limitations
Many methodological requirements for a high quality
trial are met [36]. Allocation is concealed through block-
randomization by an external researcher. Recruitment of
responders will be in the GP's waiting room, without the
GP knowing where and how randomization will take
place. The methodology used in this trial will overcome
concerns of selection bias. The relevance to the Dutch pri-
mary care seems sufficient and the generalisability of our
sample to patients in everyday practice seems high. The
sample size is large, when compared to other trials on psy-
chological problems in general practice [37]. Addition-
ally, whether the outcome is negative or positive, the
project will give a clearer understanding of who might or
might not benefit from this treatment.
Another strength of this study is the chosen primary out-
come, the self-report HADS. The HADS is a well-known
questionnaire to measure reduction of symptoms of anxi-
ety and depression. Many previous trials in psychiatry
have relied on assessments of the therapist. Another
strength is the combination of quantitative assessments
and a qualitative process evaluation. If the psychiatric
symptoms decline more in the intervention group than in
the usual care group, we can therefore safely attribute this
to PST treatment. If not, we will explore mechanisms This
will provide useful information about implementing the
intervention. A practical strength of the study is that the
intervention can take place without disturbing care as
usual, both in the study as in future implementation.
Some limitations of the present study need to be
addressed. It is possible that patients are less motivated to
attend PST treatment since screening of all participants
takes place in the waiting room of the GP's. This may be
lead to a higher dropout percentage in the PST-condition
in comparison with the dropout percentage of the CAU.
This study may be criticized because of the lack of a con-
trol group without treatment. However, patients are
always free to visit their general practitioners. Further-
more, naturalistic studies of the longitudinal course of
anxiety and depression indicate that patients who have
these symptoms longer than three months are suffering
from chronic symptoms [38,39].
Other potential criticism concerns the suitability of PST
for primary care. Although PST seems suitable for primary
care, provision of PST by trained nurses will not always be
available in daily practice of small primary care practices.
Conclusion
PST is a short psychological treatment for use in general
practice. This study delivers scientific support for this use
and therefore indications for optimal treatment and refer-
ral. Study completion is anticipated for January 2006,
with results available in May 2006.
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